Improve correctional TB testing with QuantiFERON-TB Gold Plus

On-demand webinar: combating the threat of TB through modern control methods

Correctional facilities play a critical role in controlling TB. Join Dr. Masae Kawamura as she discusses recent policy advancements that are helping prevent tuberculosis in jails and prisons. You'll learn about the latest diagnostic tools for TB infection as well as new preventative treatment regimens that are increasing compliance and decreasing cost.

In this recorded webinar, Dr. Kawamura answers top questions from your colleagues, such as how IGRA testing can help mitigate the current skin test (TST/PPD) shortage. Through case studies and publications, you'll learn why the CDC recommends modern TB blood tests and how they can streamline testing at your facility.

Dr. Masae Kawamura is a former TB Controller and current Senior Director of Scientific and Medical Affairs for TB diagnostics at QIAGEN.

REGISTER BELOW to view the on-demand webinar

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

Thank you for submitting your request. We will get back to you shortly.

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to-date licensing information and product-specific disclaimers can be found at

Terms and Conditions: Subject to your consent given above, by clicking on "submit", QIAGEN may use your personal information for internal business and marketing purposes that may include regular promotional offers, news, invitations via email or telephone. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation All information you provide in this site will be governed by our Privacy Policy.